大数跨境

文献速递丨SCI 高分文献(IF值:20.3)金属氟化物纳米调节剂通过干性重塑逆转治疗耐药性以触发焦亡用于化学-免疫联合治疗

文献速递丨SCI 高分文献(IF值:20.3)金属氟化物纳米调节剂通过干性重塑逆转治疗耐药性以触发焦亡用于化学-免疫联合治疗 金源康生物
2026-01-08
1

高分文献速递


客户单位:苏州大学


期刊:Bioactive Materials


影响因子(IF):20.3

文章题目:

Metal fluoride nanoregulators reverse therapeutic resistance via stemness remodeling to trigger pyroptosis for chemoimmunotherapy

文章摘要:


Chemoresistance and immunosuppression serve as major obstacles that compromise the therapeutic efficacy of chemoimmunotherapy. Herein, we reported a novel chemoimmunotherapy strategy employing metal fluoride to modulate Wnt/β-catenin signaling, effectively remodeling treatment resistance and eliciting pyroptosis-mediated immune activation. Through systematic screening of various nonmetallic anions (F−, Cl−, Br−, I−, CO32−, PO43−, S2−, and Se2−), we identified F− as an effective inhibitor of β-catenin expression and tumor stemness. The synergistic combination of F− with chemotherapy significantly attenuated tumor stemness and enhanced treatment efficacy. We further engineered 5-Fu@FeF2 nanomedicine (FFN-5) and investigated its chemoimmunotherapeutic effects. FFN-5 potently suppressed β-catenin expression, effectively diminishing cancer stemness while augmenting the cytotoxicity of 5-Fu, ultimately triggering pyroptosis. Local administration of FFN-5 not only inhibited tumor growth but also remodeled the immunosuppressive tumor microenvironment (TME), thereby promoting antitumor immunity. When combined with immune checkpoint blockade (ICB), this combined approach triggered a potent systemic immune response, effectively controlling both primary and distant lesions. Furthermore, the unique stemness-modulating properties of F-based nanomodulators significantly suppressed tumor metastasis. In summary, we demonstrated that F− effectively suppressed tumor stemness, and developed an innovative FFN-5 nanoplatform that enhanced chemoimmunotherapy by modulating stemness-dependent cell death mechanisms, suggesting a promising strategy to overcome resistance to cancer treatment.


原文链接:

https://doi.org/10.1016/j.bioactmat.2025.10.011  

引用产品及培养细胞:FBS-303  CT26

【声明】内容源于网络
0
0
金源康生物
金源康生物是一家专注动物血清、培养基、疫苗佐剂、细胞库及周边产品等研发与生产应用的国家级高新技术企业,奥普赛生物为金源康所属子品牌。咨询热线:400-880-5811,官方网址:www.nmjyk.com
内容 0
粉丝 0
金源康生物 金源康生物是一家专注动物血清、培养基、疫苗佐剂、细胞库及周边产品等研发与生产应用的国家级高新技术企业,奥普赛生物为金源康所属子品牌。咨询热线:400-880-5811,官方网址:www.nmjyk.com
总阅读0
粉丝0
内容0